Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

被引:22
|
作者
Yener, Oktay [1 ]
Aksoy, Fikret [1 ]
Demir, Mustafa [1 ]
Ozcelik, Alp [1 ]
Erengul, Canan [1 ]
机构
[1] Goztepe Training & Res Hosp, Dept Surg, Istanbul, Turkey
来源
TURKISH JOURNAL OF GASTROENTEROLOGY | 2010年 / 21卷 / 04期
关键词
Gallbladder stone; nonalcoholic steatohepatitis; metabolic syndrome; CORONARY-HEART-DISEASE; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; UNITED-STATES; OBESITY; IMPACT;
D O I
10.4318/tjg.2010.0128
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: We aimed to evaluate the prevalence of non-alcoholic steatohepatitis and metabolic syndrome in patients with symptomatic gallstones undergoing laparoscopic or open cholecystectomy. Methods: A study of 95 patients was performed. Simultaneous liver biopsies were taken during cholecystectomy between 2006 and 2007. There were no postoperative complications. Patients with significant alcohol intake, hepatitis B or C (virus-positive), autoimmune diseases, and Wilson's disease were excluded. Demographics, liver function tests, lipid profile, and ultrasound findings of patients with and without non-alcoholic steatohepatitis were compared. Results: A total of 95 patients completed the study. The mean age was 52.15 years, and 29 patients were male and 66 female. Fifty-two patients (55%) had biopsies compatible with non-alcoholic steatohepatitis. Conclusions: Fifty-five percent of patients with gallbladder stones had associated non-alcoholic steatohepatitis. Awareness of this association may result in an earlier diagnosis. The high prevalence of non-alcoholic steatohepatitis in patients with galbladder stone may justify routine liver biopsy during cholecystectomy to establish the diagnosis and stage and possibly direct therapy.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 50 条
  • [21] Tofogliflozin and Pemafibrate Combination Therapy Prevents Nonalcoholic Steatohepatitis (NASH) Development of Novel Metabolic Syndrome-Related NASH Model Mice
    Sasaki, Yusuke
    Asahiyama, Masato
    Kamiya, Wakana
    Sakai, Juro
    Kodama, Tatsuhiko
    Tanaka, Toshiya
    DIABETES, 2018, 67
  • [22] Normal Weight Nonalcoholic Steatohepatitis (NASH)
    Samala, Niharika
    May, Kevin P.
    Kleiner, David E.
    Loomba, Rohit
    Terrault, Norah
    Neuschwander-Tetri, Brent A.
    Hoofnagle, Jay H.
    HEPATOLOGY, 2013, 58 : 495A - 495A
  • [23] Nonalcoholic steatohepatitis (NASH) drugs market
    Sorcha Cassidy
    Basharut A. Syed
    Nature Reviews Drug Discovery, 2016, 15 : 745 - 746
  • [24] Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis
    Spiritos, Zachary
    Abdelmalek, Manal F.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [25] PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)
    Todisco, Simona
    Santarsiero, Anna
    Convertini, Paolo
    De Stefano, Giulio
    Gilio, Michele
    Iacobazzi, Vito
    Infantino, Vittoria
    BIOLOGY-BASEL, 2022, 11 (05):
  • [26] Nonalcoholic steatohepatitis and binary sludge in people with metabolic syndrome
    Radchenko, V. G.
    Seliverstov, P. V.
    Ledentsova, S. S.
    Manyakov, A. V.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (09) : 78 - +
  • [27] Nonalcoholic Steatohepatitis (NASH) is Associated with Higher Coronary Heart Disease Risk
    Siddiqui, Mohammad
    Van Natta, Mark L.
    Belt, Patricia H.
    Clark, Jeanne M.
    Tonascia, James
    Chalasani, Naga P.
    Guy, Cynthia D.
    Hameed, Bilal
    Sanyal, Arun J.
    HEPATOLOGY, 2016, 64 : 541A - 541A
  • [28] Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence
    Bril, Fernando
    Lomonaco, Romina
    Kalavalapalli, Srilaxmi
    Lai, Jinping
    Cusi, Kenneth
    DIABETES, 2019, 68
  • [29] Nonalcoholic steatohepatitis (NASH) is associated with hepatocyte mitochondrial DNA depletion.
    Haque, M
    Mirshahi, F
    Campbell-Sargent, C
    Sterling, RK
    Luketic, VA
    Shiffman, M
    Stravitz, RT
    Sanyal, AJ
    HEPATOLOGY, 2002, 36 (04) : 403A - 403A
  • [30] Nonalcoholic steatohepatitis (NASH) is associated with insulin resistance and mitochondrial structural abnormalities
    Sanyal, AJ
    Morowitz, C
    Clore, J
    Shiffman, ML
    Luketic, VA
    Sterling, R
    Ghatak, N
    GASTROENTEROLOGY, 1999, 116 (04) : A1271 - A1271